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Abstract
Background: The cellular prion protein (PrP
C) fulfils several yet not completely understood physiological functions.
Apart from these functions, it has the ability to misfold into a pathogenic scrapie form (PrP
Sc) leading to fatal
transmissible spongiform encephalopathies. Proteolytic processing of PrP
C generates N- and C-terminal fragments
which play crucial roles both in the pathophysiology of prion diseases and in transducing physiological functions
of PrP
C. A-disintegrin-and-metalloproteinase 10 (ADAM10) has been proposed by cell culture experiments to be
responsible for both shedding of PrP
C and its a-cleavage. Here, we analyzed the role of ADAM10 in the proteolytic
processing of PrP
C in vivo.
Results: Using neuron-specific Adam10 knockout mice, we show that ADAM10 is the sheddase of PrP
C and that its
absence in vivo leads to increased amounts and accumulation of PrP
C in the early secretory pathway by affecting
its posttranslational processing. Elevated PrP
C levels do not induce apoptotic signalling via p53. Furthermore, we
show that ADAM10 is not responsible for the a-cleavage of PrP
C.
Conclusion: Our study elucidates the proteolytic processing of PrP
C and proves a role of ADAM10 in shedding of
PrP
C in vivo. We suggest that ADAM10 is a mediator of PrP
C homeostasis at the plasma membrane and, thus,
might be a regulator of the multiple functions discussed for PrP
C. Furthermore, identification of ADAM10 as the
sheddase of PrP
C opens the avenue to devising novel approaches for therapeutic interventions against prion
diseases.
Background
The cellular prion protein (PrP
C), a glycosylphosphatidy-
linositol (GPI)-anchored membrane protein, plays a dual
role in the biology of the brain. It is the substrate for
the generation of its pathological isoform (PrP
Sc), which
is the principal component of prion infectivity and cau-
sally involved in the pathophysiology of prion diseases.
On the other hand, it accomplishes a multitude of phy-
siological functions ranging from neurogenesis to myelin
maintenance [1,2]. Proteolytic processing of PrP
C gener-
ating N- and C-terminal cleavage products as well as
shed full length PrP
C, is critically involved in the above
mentioned physiological and pathophysiological aspects
[2-4]. For instance, a membrane-bound, C-terminal frag-
ment of PrP
C is essential for myelin maintenance, and
shed GPI-anchorless PrP
Sc modulates prion neuroinva-
sion and prion disease phenotypes [2,5]. While b-clea-
vage is mainly observed under pathological conditions,
key proteolytic processing of PrP
C under physiological
conditions includes a-cleavage resulting in a membrane-
bound, C-terminal (C1) and a soluble, N-terminal (N1)
fragment, and ectodomain shedding of PrP
C, releasing a
GPI-anchorless form into the extracellular space [6-10]
(Figure 1). A number of target proteases have been
implicated in a-cleavage and ectodomain shedding of
PrP
C under in vitro conditions with a-disintegrin-and-
metalloproteinase (ADAM) 10 and ADAM17 as prime
candidates for both cleavage events [8,10].
ADAM10 mediates the shedding of several surface pro-
teins in close proximity to the cellular membrane.
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[11-13], neuronal adhesion molecule [14], N-cadherin
[15], and the Notch receptor [16-19]. Initially demon-
strated in cell culture experiments, ADAM10 has recently
been identified as the a-secretase of the amyloid precursor
protein (APP) in vivo [20-23]. Involvement of ADAM10 in
a-cleavage and shedding of PrP
C has been studied in cell
culture leading to some controversy [8,10]. Furthermore, a
complete Adam10 knockout in mice resulted in early
embryonic lethality making it impossible to study its influ-
ence on neuronal PrP
C processing in vivo [18]. This pro-
blem was overcome by the recent generation of a
conditional, neuron-specific Adam10 knockout mouse
(hence ADAM10 cKO or A10 cKO) [21]. Here, we used
these ADAM10 cKO mice to study the effects of
ADAM10 on proteolytic processing of PrP
C.W es h o w
that ADAM10 is responsible for ectodomain shedding of
PrP
C and that its absence results in PrP
C accumulation in
the early secretory pathway. Additionally, we demonstrate
that ADAM10 is not responsible for a-cleavage of PrP
C.
Results
Lack of ADAM10 leads to posttranslational increase of
PrP
C
Indirect evidence suggested that ADAM10 modulates
PrP
C levels [24]. A recently published, novel conditional
knockout model lacking ADAM10 specifically in
n e u r o n sa l l o w e du st oa s s e s st h i sn o t i o nin vivo [21].
Here, we used primary neurons and brain sections of
A D A M 1 0c K Om i c ea te m b r y o n i cd a y1 4( E 1 4 )t o
investigate the expression and localisation of PrP
C. Lack
of ADAM10 resulted in increased levels of PrP
C as
shown by Western blot analysis (Figure 2A). After quan-
tification, PrP
C amounts were increased by a factor of
1.94 (standard error of mean, SEM: 0,096) when com-
pared to PrP
C levels in neuronal lysates derived from
age-matched wildtype embryos (set as one), with Nestin-
Cre-negative littermates (Controls) showing values of
1.19 (SEM: 0,117). Thus, PrP
C levels were increased by
63% in ADAM10 cKO compared to littermate controls
and differences were significant (p = 0,0013). Assess-
ment of the contribution of di-, mono- and unglycosy-
lated PrP
C to the total signal of PrP
C in Western blot
analysis of ADAM10 cKO and control neurons revealed
comparable glycoprofiles showing that ADAM10-related
PrP
C increase did not alter the extent of glycosylation of
PrP
C (data not shown). In accordance with published
data, morphological analysis of ADAM10 cKO mice and
controls at E14 did not show alterations in the gross
cortical organisation [21]. An enhanced immunosignal
for PrP
C was observed in all cortical and subcortical
regions (Figure 2B) as well as in the spinal cord includ-
ing sensory ganglia when compared to littermate con-
trols with a staining pattern showing increased signal
Figure 1 Proteolytic cleavage of PrP
C. After cleavage of the N-terminal and GPI anchor signal peptides (grey), mature membrane-bound PrP
C
can undergo at least three different proteolytic cleavage events (scissors) in addition to phospholipase C cutting within its GPI anchor. While b-
cleavage is mainly observed under pathological conditions, a role of ADAM10 is discussed in the context of both, constitutive a-cleavage and
shedding of PrP
C. The resulting fragments are shown underneath. Striped box: octameric repeat region; checked box: hydrophobic core domain.
Epitopes of PrP
C specific monoclonal antibodies POM1 and POM2 used in this study are indicated.
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C but unaltered mRNA levels in ADAM10 cKO mice. (A) Western blot analysis for PrP
C in primary neurons
of Prnp
0/0, wt, ADAM10 cKO and Nestin-Cre-negative littermate controls (all from E14 embryos). Quantification of PrP
C amounts shows a statistically
significant increase of PrP
C in ADAM10 cKO neurons compared to littermate controls (p = 0,0013). All samples were normalized to wildtype which
was set to one (n = 3 for wt and Prnp
0/0; n = 5 for A10 cKO and Ctrl) (d, m, u = di-, mono-, unglycosylated PrP
C; representative blot is shown).
Immunohistochemical staining of PrP
C in brains (B) and dorsal root ganglia (C) of E14 ADAM10 cKO mice and littermate controls shows enhanced
immunosignal throughout the entire central nervous system with some degree of variation between individual neurons in ADAM10 cKO mice (C,
scale bar: 20 μm). Brain of an age-matched Prnp
0/0 mice was taken as negative control in B. (B, upper row: whole brain section, scale bar: 500 μm;
bottom row: magnification of inserts, scale bar: 50 μm). (D) Quantitative RT-PCR for PrP
C mRNA in brain homogenates of ADAM10 cKO and
wildtype littermate controls shows no significant difference in expression levels between genotypes at E14 (n = 4) and P1 (n = 3).
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ipheral nervous system (Figure 2C). Since we were inter-
ested in defining whether the increase in PrP
C is due to
transcriptional upregulation or due to posttranslational
mechanisms, we quantified neuronal PrP
C mRNA levels
by quantitative RT-PCR. No significant differences were
detectable between wildtype littermate controls (set as
one) and ADAM10 cKO neurons when assessed at E14
(A10 cKO: relative value = 1,037; SEM = 0,078; SEM
Ctrl = 0,160; p = 0,79) or postnatal day 1 (A10 cKO: rel.
value = 0,935; SEM = 0,175; SEM Ctrl = 0,195; p =
0,82) (Figure 2D). Thus, increased PrP
C levels in brains
and primary neurons of ADAM10 cKO mice are not
caused by transcriptional upregulation but are rather
due to posttranslational mechanisms.




C is present both in intracellular compartments and
on the plasma membrane. Thus, we were interested in
examining the subcellular distribution of PrP
C and in
locating its increase in ADAM10 cKO compared to wild-
type littermate neurons. To this aim, we performed con-
focal and spinning disc immunofluorescence microscopy
using a PrP
C-specific antibody. Staining intensities of
PrP
C at the plasma membrane appeared unaltered in
ADAM10 cKO neurons when compared to controls
(data not shown). However, in permeabilized control
neurons, PrP
C was localized in vesicular structures that
were evenly distributed within the soma, whereas in
ADAM10 cKO neurons, dense PrP
C accumulations were
found in intracellular compartments adjacent to the
nucleus and along neuronal processes (Figure 3A). To
determine the localization of these dense PrP
C accumula-
tions in more detail we performed co-stainings of PrP
C
with organelle markers in ADAM10 cKO neurons and
controls. Control neurons showed a partial, vesicular
colocalization with all three markers, reflecting the bio-
synthesis, trafficking and degradation of PrP
C.A g a i n ,
dense aggregates of PrP
C were only found in ADAM10
cKO neurons. These accumulations of PrP
C colocalized
with ER marker PDI and with Golgi marker GM130 (Fig-
ure 3B). No significant colocalization of dense PrP
C accu-
mulations, but a partial, vesicular colocalization of PrP
C
with lysosomal marker LAMP1 was found, reflecting the
physiological turnover of PrP
C. These findings identify
retention of PrP
C within the early secretory pathway
rather than an interrupted degradation as the cause for
increased PrP
C levels seen in the absence of ADAM10.
Expression and activation of p53 is not altered by
increased levels of PrP
C in ADAM10 cKO
Increased expression of PrP
C has been shown to induce
p53-related pathways [25,26]. Therefore, we decided to
investigate p53-related signalling in our model of
ADAM10-related PrP
C increase. Interestingly, we did
not observe any evidence for induction of p53 at the
protein level by Western blot analysis of neuronal
lysates (Figure 4A). These data were confirmed by quan-
titative RT-PCR for p53 mRNA where there was no sig-
nificant difference between ADAM10 cKO and
littermate controls (set as one) when assessed at E14
(A10 cKO: rel. value = 1,07; SEM = 0,13; SEM Ctrl =
0,16; p = 0,75) and P1 (A10 cKO: rel. value = 1,24; SEM
= 0,16; SEM Ctrl = 0,17; p = 0,37) (Figure 4B). In order
to study a possible regulatory influence of increased
PrP
C on p53-dependent signalling, we also analyzed
mRNA levels of Mdm2 (Figure 4B) and p21 (encoded
by the Cdkn1a gene; data not shown), two essential co-
regulated targets in p53-related pathways [27]. No sig-
nificant differences between neurons of ADAM10 cKO
and littermate controls were detected (Mdm2 at E14:
A10 cKO: rel. value = 1,38; SEM = 0,39; SEM Ctrl =
0,24; p = 0,44/Mdm2 at P1: A10 cKO: rel. value = 1,16;
SEM = 0,22; SEM Ctrl = 0,11; p =0 , 5 6 ) .T h u s ,a n
ADAM10-related increase in PrP
C unlikely leads to the
activation of p53-related pathways.
a-cleavage of PrP
C in ADAM10 cKO mice
It was previously suggested that ADAM10 is responsible
for the a-cleavage of PrP
C, giving rise to the membrane-
bound C1 and the soluble N1 fragment (Figure 1) [8,9].
Our ADAM10 cKO mice allowed us to investigate this
hypothesis in primary neurons and total brain homoge-
nates. First, we analyzed via immunoblotting the Adam10
deletion efficiency in neuronal lysates from ADAM10
cKO, ADAM10 littermate controls, wildtype, tga20,a n d
Prnp
0/0 mice (Figure 5A). ADAM10 cKO neurons showed
a nearly complete loss of ADAM10 with heterozygous lit-
termates (A10 het.) showing a reduction in the expression
of both premature (pADAM10) and mature ADAM10
(mADAM10) when compared to Nestin-Cre-negative lit-
termate controls (Ctrl), indicating a dose-dependency in
gene expression (Figure 5A; lanes 4-6). The relative
increase of pADAM10 in wildtype neurons was most likely
due to differences in the efficiency of neuronal lysis and
was not seen in neuronal lysates from different wildtype
mice (Additional file 1A). Analysis further revealed that
lack (Prnp
0/0)o rt r a n s g e n i co v e r e x p r e s s i o no fP r P
C (tga20)
did not modulate the levels of pADAM10 or mADAM10.
Again, Western blot analysis for PrP
C confirmed the
increase of PrP
C in ADAM10 cKO neurons described
above. Upon deglycosylation with PNGase F, C1 became
detectable as a band of approx. 16 kDa. We could detect
C1 irrespectively of the ADAM10 status of neurons (Fig-
ure 5A; complete Western blot of PNGase F digestion is
shown in Additional file 1B). In fact, C1 signal strength
was stronger in tga20 and ADAM10 cKO neurons arguing
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C accumulates in intracellular compartments in ADAM10 cKO neurons. (A) Confocal (upper two rows; scale bar overview: 100
μm, scale bar single neuron: 10 μm) and spinning disc (lower two rows; scale bar YZ-sections: 10 μm) immunofluorescence microscopy for PrP
C
in permeabilized wildtype neurons (Ctrl) shows PrP
C in evenly distributed vesicular structures (open arrowhead). In ADAM10 cKO neurons, dense
PrP
C accumulations are detectable adjacent to the nucleus (filled arrowhead) and in neuronal processes. YZ-sections through individual neurons
confirm these findings (arrow for PrP
C accumulation in ADAM10 cKO). Asterisks mark nuclei. (B) Confocal microscopic analysis of co-stainings of
PrP
C (left column) with intracellular organelle marker proteins (middle column) in wildtype littermate (Control) and ADAM10 cKO neurons.
Overlays are shown in the right column. Accumulations of PrP
C are only found in ADAM10 cKO neurons (filled arrowheads in d, j, and p) and
colocalize with protein disulfide isomerase (PDI) used as marker for ER (e, f) and Golgi marker GM130 (k, l). Partial colocalization of PrP
C with the
lysosomal marker LAMP1 is detectable in vesicular structures (q, r). Scale bars represent 10 μm. Asterisks in overlays mark nuclei.
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C rather than the presence of
ADAM10 correlates with the appearance of C1. Increased
levels of PrP
C and C1 were also found in brain homoge-
nates of ADAM10 cKO mice at E14 when compared to
wildtype littermate controls (Figure 5B). Furthermore, the
corresponding, soluble N1 fragment of approx. 11 kDa
was immunoprecipitated from supernatants of primary
neurons and was present in all samples except for Prnp
0/0
neurons (Figure 5C and Additional file 1C). As with C1,
the N1 fragment appeared to be increased in supernatants
of ADAM10 cKO neurons when compared to wildtype
controls. In summary, a-cleavage occurs in the absence of
ADAM10, challenging the role of ADAM10 in this proces-
sing step of PrP
C in vivo.
ADAM10 cKO mice do not shed PrP
C
ADAM10 plays important roles in regulated intramem-
brane proteolysis and in vitro studies suggest that
ADAM10 is involved in shedding of PrP
C at the plasma
membrane [10]. Here, we investigated this issue using
ADAM10 cKO primary neurons and performing immuno-
precipitations of shed PrP
C from conditioned media. Fol-
lowing SDS-PAGE and immunoblotting, we observed an
almost complete lack of shed PrP
C in culture supernatants
from ADAM10 cKO neurons (Figure 6A; tga20: rel. value
= 2,85; SEM = 0,49; A10 cKO: rel. value = 0,24; SEM =
0,08; Ctrl: rel. value = 1,07; SEM = 0,15; p = 0,0026). An
additional blot for shed PrP
C is shown in Additional file
1C). Immunoprecipitated shed PrP
C showed a slightly dif-
ferent running behaviour in gel electrophoresis when com-
pared to PrP
C in neuronal lysates. This shift of 2 kDa
reflects the truncation of shed PrP
C, which lacks the GPI
anchor and two C-terminal amino acids. To determine
whether the lack of shedding is directly linked to the
absence of ADAM10, we carried out rescue experiments
by expressing ADAM10 in neural stem (NS) cells derived
from ADAM10 cKO mice, followed by neuronal differen-
tiation. Importantly, re-expression of ADAM10 led to
reappearance of shed PrP
C in supernatants of neuronally
differentiated NS cell cultures transfected with Adam10,
but not in supernatants of mock-transfected control cul-
tures (Figure 6B). Based on these results, we conclude that
ADAM10 is both necessary and sufficient to release PrP
C
from the neuronal surface.
Discussion
PrP
C is in the focus of research because of its unique
ability to act as an infectious agent in its misfolded form
[28,29]. Furthermore, its physiological functions are
manifold ranging from neurogenesis to binding of beta-
amyloid [1,30]. Both aspects are influenced by proteoly-
tic processing of PrP
C (Figure 1A; reviewed in [7]).
Shedding at the plasma membrane, a-cleavage within
the hydrophobic core, and b-cleavage subsequent to the
octameric repeat region have been described for PrP
C
[6,8,31-33]. However, all studies aimed at identifying the
respective proteases have been performed using cell
lines. For a-cleavage and shedding, the metalloprotei-
nase ADAM10 has been suggested as the responsible
protease [8-10]. Neuron-specific conditional ADAM10
knockout mice allowed us to address the role of
ADAM10 for PrP
C processing in vivo [21].
Since a causal relationship between ADAM10 levels
and PrP
C amounts has been postulated, we measured
PrP
C levels in ADAM10 cKO mice [24]. We found a sig-
nificant increase in PrP
C protein levels in ADAM10 cKO
mice, while mRNA levels remained unaltered. Micro-
scopic analysis showed an ADAM10-dependent intracel-
lular accumulation of PrP
C in perinuclear compartments,
but an unaltered expression pattern at the neuronal cell
surface. This observation indicates that posttranslational
mechanisms rather than transcriptional upregulation
Figure 4 No induction of p53 or p53-regulated pathways in
ADAM10 cKO. (A) Western blot analysis in lysates of primary
neurons from Prnp
0/0, wt, tga20, ADAM10 cKO and littermate
controls (all from E14 embryos) shows comparable protein amounts
of p53. (B) Using quantitative RT-PCR, relative mRNA levels of p53
and its downstream signalling target Mdm2 were determined in
brain homogenates of ADAM10 cKO mice and wildtype littermates
controls at E14 (n = 4) and P1 (n = 3). No significant differences in
expression levels of p53 and Mdm2 were observed between
genotypes at both ages (E14: p = 0,75 for p53 and p = 0,44 for
Mdm2; P1: p = 0,37 for p53 and p = 0,56 for Mdm2).
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C levels in the absence of
ADAM10 and contrasts a study where overexpression of
ADAM10 led to downregulation of PrP
C at the mRNA
level [24]. Since we found PrP
C accumulations to be
located in the ER and Golgi apparatus, we postulate that
PrP
C is retained within these organelles in cells lacking
ADAM10. In view of unaltered mRNA levels, constitutive
biosynthesis in combination with the strong retention in
the early secretory pathway seems to be the main reason
for increased PrP
C levels in ADAM10 cKO mice.
PrP
C overexpression has been shown to downregulate
beta-site APP-cleaving enzyme 1 (BACE1) in a glycosa-
minoglycan-dependent manner [34]. Interestingly,
ADAM10 cKO mice show reduced APP-processing
activity of BACE1 [21]. Thus, the data presented here
provide a rationale for this phenomena linking
ADAM10-related increase of PrP
C to reduction of
BACE1 activity.
The interaction of PrP
C and p53 has been highlighted
recently with overexpression of PrP
C leading to induc-
tion of p53-dependent pro-apoptotic pathways and p53
controlling expression of PrP
C via promoter transactiva-
tion [25,26,35,36]. In view of the fact that ADAM10
cKO mice die perinatally and show a degree of
neurodegeneration that can only partially be explained
by altered Notch signalling [21], PrP
C-related induction
of p53-dependent apoptosis seemed an attractive
mechanism to explain this phenotype, in particular
because of the increased amount of PrP
C found in these
animals. However, we were unable to detect any dysre-
gulation of p53-related pathways in our ADAM10 cKO
neurons, which is in contrast to the study by Liang et
al. who found a link between inducible upregulation of
PrP
C and p53-dependent apoptosis [25,26,35,36]. Rather,
our results are in line with a recent study showing cellu-
lar imbalance but unaltered p53 levels in response to
PrP
C overexpression [37]. A recently published model
states that p53 transcription is upregulated by the for-
mation of the amyloid intracellular domain (AICD) dur-
ing presenilin-dependent g-secretase cleavage of APP
with increased p53 subsequently activating PrP
C tran-
scription [36]. Since production of the APP C-terminal
fragment as a prerequisite for AICD formation is
reduced in ADAM10 cKO mice [21], our findings of
unaltered PrP
C and p53 mRNA levels fit into this
concept.
The a-cleavage of PrP
C, which takes place in the late
secretory pathway [38], has been shown to be of utmost
Figure 5 ADAM10 is not responsible for a-cleavage of PrP
C. (A) Western blot analysis for premature (pADAM10) and mature ADAM10
(mADAM10; upper row), PrP
C (second row), PrP
C C1 fragment after PNGase F treatment (third row), and actin (bottom row) in neuronal cultures
from Prnp
0/0, wt, tga20, ADAM10 cKO and littermate controls at E14. Levels of ADAM10 are dramatically reduced in ADAM10 cKO when
compared to cultures from littermate controls or from mice overexpressing or lacking PrP
C. In accordance with figure 2, PrP
C levels are increased
in ADAM10 cKO and there is no influence of ADAM10 status on the presence of the C1 fragment, which is most abundant in neuronal lysates
with elevated expression of PrP
C (i.e. ADAM10 cKO and tga20). (B) Western blot analysis for PrP
C in brain of ADAM10 cKO and littermate controls
at E14 confirms increased PrP
C and the presence of the C1 fragment in ADAM10 cKO mice in an in vivo setting. (C) Western blot analysis for
PrP
C in lysates of ADAM10 cKO and wildtype neurons (both from E14 mice embryos) confirms increased PrP
C amounts in the absence of
ADAM10. Soluble N1 fragment was immunoprecipitated (IP) from culture supernatants of these neurons and is found to be increased in
supernatants derived from ADAM10 cKO neurons.
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forms of PrP
C lead to neurodegeneration in transgenic
mice [39-41]. Secondly, the N1 fragment can counteract
experimentally induced p53-dependent caspase-3 activa-
tion in vitro and in vivo, indicating a neuroprotective
function [42]. Thirdly, the corresponding C1 fragment
was shown to act in trans on adjacent Schwann cells
maintaining myelination [2], and it has been proposed
to activate apoptotic pathways leading to neuronal death
[3]. The a-cleavage occurs within the hydrophobic core,
one of the most highly conserved domains of PrP
C,
which underlines the importance of this processing [43].
Thus, elucidating the nature of the responsible protease,
recently termed a-PrPase, will help in understanding the
physiological functions of PrP
C and the pathophysiology
of prion disease [6,44,45]. Since ADAM10 was suggested
to be the a-PrPase [8,9,46], we assessed this in our
m o d e l .T h ef a c tt h a tw ef o u n di n c r e a s e dl e v e l so fC 1
and N1 in primary neurons and total brain homogenates
of ADAM10 cKO embryos clearly argues against invol-
vement of ADAM10 in a-cleavage of PrP
C with
increased amounts of PrP
C in ADAM10 cKO yielding
elevated levels of C1 and N1. Although a varying
PNGase F digestion efficiency could partially contribute
to enhanced C1 presence in A10 cKO neurons com-
pared to tga20 in Figure 5A, we speculate that ADAM10
negatively regulates a-cleavage possibly by inhibiting the
responsible protease. Our findings are in line with in
vitro results of Taylor and colleagues, who were also
unable to directly link ADAM10 expression or silencing
to C1 prevalence [10]. Thus, the a-PrPase, which has
recently been shown to tolerate severe modifications
within the PrP
C sequence [45], still needs to be
identified.
ADAM10 is the sheddase of a number of transmem-
brane proteins and was linked to constitutive shedding
of PrP
C using cell lines overexpressing PrP
C [10,47].
Here, we investigated the role of ADAM10 in PrP
C pro-
cessing in a physiological context in vivo. In agreement
with in vitro data, we found an almost complete lack of
PrP
C shedding in ADAM10 cKO mouse neurons.
Furthermore, genetic introduction of Adam10 into
Figure 6 ADAM10 is responsible for the shedding of PrP
C. (A) Shed PrP
C was immunoprecipitated (IP) from culture supernatants of primary
neurons derived from Prnp
0/0, wt, tga20, ADAM10 cKO and littermate control mice (all from E14 embryos) and visualized by Western blot
analysis for PrP
C. Shed PrP
C, which shows a 2-3 kDa shift when compared to PrP
C in lysates, is only detectable in wt, tga20, and littermate
control neurons. Supernatants from ADAM10 cKO neuron cultures contain virtually no shed PrP
C. IgG light chain (IgG-LC) of capture antibody is
detectable at 25 kDa (representative blot is shown). Quantification confirms a significant reduction (p = 0,0026) of the amounts of shed PrP
C
shedding in ADAM10 cKO compared to littermate control cultures (Prnp
0/0 values were defined as background and subtracted from the values
of all other genotypes; wildtype values were set to one; n = 3 for tga20; n = 5 for A10 cKO and Ctrl). (B) Neural stem (NS) cells derived from an
ADAM10 cKO mouse embryo at E14 were transfected (TF) without (+mock) or with Adam10-ORF (+A10). Following neuronal differentiation, PrP
C
was immunoprecipitated from culture supernatants (bottom row; IgG-LC = IgG light chain of capture antibody) and detected in corresponding
cell lysates (second row; d, m, u = di-, mono-, unglycosylated PrP
C) by Western blotting. Shed PrP
C reappears in Adam10- but not in mock-
transfected cultures (bottom row). Success of transfection was verified by Western blot detection of pADAM10 and mADAM10 in cell lysates (top
row). Actin is shown as control (third row).
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we were able to identify ADAM10 as the functionally
relevant sheddase of PrP
C, which is further supported by
the increase in PrP
C protein levels in ADAM10 cKO
mice discussed above. Based on our results, we propose
a model where shedding by ADAM10 is a mechanism
to regulate the PrP
C amount at the cellular membrane.
When shedding is impaired, the cell reacts with reten-
tion of PrP
C in the early secretory pathway rather than
allowing it to accumulate at the plasma membrane. In
view of the multiple functions discussed for PrP
C,o u r
findings indicate the importance of tightly controlled
amounts of PrP
C at the neuronal surface.
Conclusion
Our data show that ADAM10 does not perform a-clea-
vage but shedding of PrP
C, with lack of ADAM10 activ-
ity leading to increased amounts of PrP
C due to its
retention within early secretory compartments. These
data further underscore the physiological relevance of
proteolytic processing of PrP
C and shed light on the nat-
ure of the PrP
C-sheddase. Yet, its impact on the course
of prion disease is not known in detail. While a recent
in vitro study showed no shedding-dependent modula-
tion of prion conversion [10], incubation times after
scrapie inoculation were prolonged in mice overexpres-
sing Adam10 [24]. Further studies of proteolytic proces-
sing of PrP
C may provide novel approaches for
therapeutic interventions against prion diseases.
Methods
Generation of murine primary neuronal cultures
Primary neurons were obtained from E14 embryos of
Adam10 conditional knockout mice (Adam10
Fl/Fl Nes-
tin-Cre-positive; ADAM10 cKO or A10 cKO) [21,48].
Adam10
Fl/+ Nestin-Cre-positive (A10 heterozygous) and
Adam10
Fl/+ Nestin-Cre-negative (A10 wildtype control
or Ctrl) embryos served as littermate controls. Further
controls included prion protein knockout embryos
(Prnp
0/0;[ 4 9 ] ) ,w i l d t y p ee m b r y o s( w t ;C 5 7 B L / 6 ) ,a n d
prion protein overexpressing embryos (tga20; [50]).
Briefly, embryonic brains were isolated, trypsinized, and
cell suspensions were seeded on poly-L-lysine coated
(Sigma) cell culture dishes (Sarstedt) in B-27 containing
neurobasal medium (Invitrogen) as described previously
[51]. Non-neuronal cells were eliminated by treatment
with 5 μM cytosine arabinoside (Sigma) 24 h after plat-
ing. After four days, primary neurons were cultivated for
additional 24 h in medium lacking B-27. Culture super-
natants were collected for immunoprecipitation experi-
ments and cells were lysed for Western blot analysis as
described below. All animal procedures were performed
in accordance with the institutional guidelines from the
animal facility of the University Medical Center Ham-
burg-Eppendorf.
Immunoprecipitation of PrP
C from conditioned media
Protease inhibitor cocktail (PI; Roche) was added to the
supernatants. After centrifugation for 5 min at 3,000 × g
and 4°C, volumes were normalized according to the
total protein content of corresponding cell lysates (see
below) and supernatants (approx. 4 ml) were concen-
trated by use of Amicon Ultra centrifugal filters 3 kDa
MWCO (Millipore) at 5,000 × g and 4°C. 2 μg of mouse
monoclonal antibody POM2 (A. Aguzzi, Zürich, Swit-
zerland), recognizing repetitive epitopes within the N-
terminus of PrP
C, were added to 500 μl of concentrated
supernatants, and antibody binding was allowed for 16 h
at 4°C on a rotating wheel. Protein G sepharose beads
“4F a s tF l o w ” (GE Healthcare) were washed 3× with
RIPA buffer (50 mM Tris-HCl pH8, 150 mM NaCl, 1%
NP40, 0,5% Na-Deoxycholat, 0,1% SDS) containing PI.
50 μl of a 1:1 suspension of beads in RIPA buffer was
then added to the supernatant-antibody solution. After
1 h of incubation under rotation at 4°C, complexes were
washed with RIPA buffer and boiled for 6 min with 2×
loading buffer. Eluates were subsequently separated
from the beads by centrifugation and then subjected to
SDS-PAGE as described below.
Western blot analysis of primary neuronal cultures and
brain homogenates
Primary neurons were washed 2× with ice-cold PBS
(PAA laboratories) and then lysed in RIPA buffer con-
taining PI. Centrifugation for 5 min at 12,000 × g and 4°
C was performed to get rid of DNA and cellular debris.
Brain homogenates were prepared as described pre-
viously [52]. Protein concentrations were determined by
Bradford assay (Biorad). For detection of the PrP
C C1
fragment, 30 μg of total protein was resuspended in
digestion buffer (25 mM Tris-HCl pH7.5, 0,5% SDS, 1%
b-mercaptoethanol) and boiled for 5 min. 1% Nonident
P-40 (Fluka) and 5U of N-glycosidase F (PNGase F;
Roche) were added and deglycosylation was allowed for
16 h at 37°C. Finally, samples were mixed with 4× load-
ing buffer (250 mM Tris-HCl pH6.8, 8% SDS, 40% gly-
cerol, 20% b-mercaptoethanol, 0,008% bromphenol
blue), boiled for 6 min at 95°C, and electrophoretically
separated using 12% Tris/glycine gels. Proteins were
transferred to nitrocellulose membranes (Biorad) and
detected using mouse monoclonal antibodies to PrP
C
(POM1, 1:2,500 and POM2, 1:5,000; A. Aguzzi, Zürich,
Switzerland) or to b-actin (1:5,000; Sigma), rabbit mono-
clonal antibody to p53 (1:1,000; Santa Cruz), and rabbit
polyclonal antibody to ADAM10 (P. Saftig, Kiel,
Germany), as well as the respective anti-mouse or
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immunoprecipitated N1 fragment, POM2 was used for
pull-down and detection. Blots were developed with
SuperSignal West Pico (Pierce). Quantifications were
performed using Universal Hood II and Quantity One
4.6.2 software (Biorad).
Generation, nucleofection, and differentiation of neural
stem cell cultures
To derive adherently growing neural stem (NS) cells
from ADAM10 cKO mice, we first established neuro-
s p h e r ec u l t u r e sf r o mt h eg a n g l i o n i ce m i n e n c eo fE 1 4
embryos using standard protocols (see e.g. [53]). Neuro-
spheres from the third passage were enzymatically disso-
ciated using Accutase (PAA Laboratories), cells were
plated into gelatine-coated tissue culture flasks and
further cultivated in NS-A medium (Euroclone) supple-
mented with 10 ng/ml fibroblast growth factor-2 (FGF-
2), 10 ng/ml epidermal growth factor (EGF) (both from
TEBU) and 1% modified N2 [54]. To express ADAM10
in ADAM10 cKO NS cells, mouse Adam10 cDNA was
cloned into pcDNA3.1/Zeo(-) (Invitrogen), and the plas-
mid was linearized with Bgl II and used to transfect the
cells with the Nucleofector
® technology (Lonza) as
described [55]. Mock transfections were performed with
linearized pcDNA3.1/Zeo(-) lacking the Adam10 cDNA.
In brief, about 5 × 10
6 NS cells were resuspended in
100 μl Nucleofector
® solution containing 10 μg of line-
arized DNA, and cells were nucleofected using the
Nucleofector
® program A033. Transfected cells were
plated into tissue culture flasks coated with poly-L-
ornithine and 1% Matrigel (Becton Dickinson), and
expanded in NS-A containing 10 ng/ml FGF-2, 10 ng/
ml EGF, 1% B27 (Invitrogen), 1% modified N2 and 200
μg / m lz e o c i n .T oi n d u c en e u r o n a ld i f f e r e n t i a t i o no f
ADAM10- and mock-nucleofected ADAM10 cKO NS
cells, cells were first cultivated for four days in NS-A
supplemented with 5 ng/ml FGF-2, 2% B27, and 1%
modified N2, followed by another four days in a 1:1
mixture of NS-A and Neurobasal (Invitrogen) supple-
mented with 2% B27 and 0.25% modified N2. Superna-
tants from differentiated cultures were collected and
subjected to immunoblot analysis.
Sample preparation and immunohistochemical analysis
Embryos were dissected and fixed by immersion in 4%
buffered formalin for 24 h, dehydrated in ascending
ethanol concentrations, and embedded in low-melting-
point paraffin following standard laboratory procedures.
4 μm sections were submitted to immunostaining fol-
lowing standard immunohistochemistry procedures
using the Ventana Benchmark XT machine (Ventana).
Briefly, deparaffinated sections were boiled for 30 min
in CC1 buffer (Ventana) for antigen retrieval. Sections
were then incubated with primary antibody POM1
(1:100) in 5% goat serum (Dianova), 45% Tris buffered
saline pH7.6, 0,1% Triton X-100 in antibody diluent
solution (Zytomed) for 1 h, followed by detection with
Mouse Stain Kit (Nichirei Biosciences) for the detection
of murine primary antibodies on murine tissue. Anti-
body detection was performed with an ultraview univer-
sal DAB detection kit (Ventana) followed by
counterstaining according to the standard settings of the
machine. As negative controls primary antibodies were
omitted.
Quantitative RT-PCR
RNA was extracted from entire brains of E14 (n = 4)
and P1 (n = 3) Adam10 cKO and littermate control ani-
mals using the NucleoSpin RNAII kit (Macherey Nagel).
RNA concentration was determined using the Nano-
Drop system (Thermo Scientific). First-strand cDNA
was synthesized using 1 μg of total DNase-treated RNA
in a 20 μl reverse transcriptase reaction mixture follow-
ing the instructor manual (High Capacity cDNA Reverse
Transcription Kit; Applied Biosystems). All Real-Time
PCR reactions were performed in a 10 μlm i x t u r ec o n -
taining 10 ng of cDNA preparation (1 μl), 2XSYBR
®
Green PCR Master Mix (Applied Biosystems), and 0.2
μM of each primer. The following primer pairs were
used: murine Prnp gene (AATGCTTACCGTGT-
GACCC; CATGCAGATTCAAAGACCAGC), murine





titations were performed using the ABS 7500 Fast Real-
Time PCR System (Applied Biosystems). Fluorescence
threshold value was calculated using the 7000 system
SDS-software. The Gapdh gene (primers: GGTGAAGG
TCGGTGTGAAC; GGGGTCTCGCTCCTGGAA) was
used as a reference to compare the relative expression
level of target genes.
Immunofluorescence analysis
Primary neurons were grown on poly-L-Lysine (Sigma)
coated coverslips. After washing in PBS, cells were fixed
in 4% paraformaldehyde, washed and treated with 0,1 M
glycine solution. Cells were permeabilized using 0,2%
Triton X-100 and unspecific epitopes were blocked with
2% BSA solution. PrP
C was detected using POM1 anti-
body (1:200) and Alexa Fluor
® 488-conjugated donkey
anti-mouse secondary antibody (1:500; Invitrogen). For
colocalization studies antibodies against PDI (rabbit;
1:100; Stressgen), GM130 (rabbit; 1:50; Abcam), and
LAMP1 (rat; 1:50; Hybridoma Bank) were used to visua-
lize ER, Golgi, and lysosomes, respectively. Secondary
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® 555 donkey anti-rabbit and
anti-rat (Invitrogen) were diluted 1:500. Analysis was
performed using an Improvision LiveCell Spinning Disk
(Zeiss) or a TCS SP2 confocal microscope (Leica) and
Volocity software (Perkin Elmer).
Statistical analysis
Statistical comparison of Western blot quantifications
and qPCR results between A10 cKO and littermate con-
trol samples was performed using Student’st - t e s tw i t h
consideration of statistical significance at p-values < 0,05
(*) and <0,01 (**).
Additional material
Additional file 1: (A) Western blot analysis for premature
(pADAM10) and mature ADAM10 (mADAM10; upper row) and b-
actin (lower row) in neuronal cultures from Prnp
0/0, wt, tga20,
ADAM10 cKO and littermate controls at E14. Levels of ADAM10 are
dramatically reduced in ADAM10 cKO when compared to cultures from
littermate controls or from mice overexpressing or lacking PrP
C. (B)
Western blot analysis for PrP
C after PNGase F treatment in neuronal
lysates from Prnp
0/0, wt, tga20, ADAM10 cKO and littermate controls at
E14 showing partially digested full-length prion protein and C1 fragment.
(C) Shed PrP
C was immunoprecipitated (IP) from culture supernatants of
primary neurons derived from Prnp
0/0, wt, tga20, ADAM10 cKO and
littermate control mice (all from E14 embryos) and visualized by Western
blot analysis for PrP
C. Shed full-length PrP
C, which shows a 2-3 kDa shift
when compared to PrP
C in lysates, is only detectable in wt, tga20, and
littermate control neurons. Supernatants from ADAM10 cKO neuronal
cultures contain virtually no shed full-length PrP
C, whereas the soluble
N1 fragment becomes detectable even in these ADAM10 cKO samples
when POM2 is used for pull-down and detection. IgG light chain (IgG-
LC) of capture antibody is detectable at 25 kDa.
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